Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editorial staff interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

Dr. Casanova studies the genetics of human predisposition to pediatric infectious diseases, particularly mycobacterial diseases, invasive pneumococcal diseases, and herpes simplex encephalitis. He is interested in identifying Mendelian "holes" in the immune defense of otherwise healthy children who are susceptible to specific infectious diseases, work that has resulted in a paradigm shift in human clinical medicine and fundamental immunology.

Dr. Casanova's laboratory aims to understand what it is that makes some children develop a severe clinical illness in the course of infection while others exposed to the same microbe remain unharmed. In the past decade, the Casanova and Abel laboratory in Paris revealed that single genetic lesions in children confer severe and selective vulnerability to certain illnesses, whereas corresponding infections in adults result more from polygenetic inheritance. This work not only blurs the distinction between patient-based Mendelian genetics and population-based complex genetics but has also provided experimental support for a unified theory of human infectious diseases.

During this week's podcast, Dr. Casanova provides additional evidence that infectious diseases are also genetic, perhaps even more so than any other group of human disease, despite the prevailing view that infectious diseases are essentially environmental. He discusses his novel theory of primary immunodeficiencies and elaborates on the concept of Mendelian holes. Dr. Casanova also explains the profound clinical implications that result from the study of these Mendelian holes.
Dr. Casanova received his M.D. from the University of Paris René Descartes in 1987 and his Ph.D. in immunology from the University of Paris Pierre et Marie Curie in 1992, after being trained at the Pasteur Institute in Paris and the Ludwig Institute for Cancer Research in Lausanne. Following a residency in pediatrics in Paris, he completed a clinical fellowship in the pediatric immunology-hematology unit of the Necker Medical School in Paris. In 1999 he was appointed a professor of pediatrics at Necker, where, with Dr. Abel, he cofounded and codirected the Laboratory of Human Genetics of Infectious Diseases. He was appointed professor at Rockefeller University in 2008. Dr. Casanova was an international research scholar with the Howard Hughes Medical Institute from 2005 to 2008 and is a member of the European Molecular Biology Organization and the American Society for Clinical Investigation. Dr. Casanova is the recipient of the 2008 Richard Lounsbery Award from the French and American Academies of Sciences and a Professor Lucien Dautrebande Pathophysiology Foundation Prize from the Belgian Royal Academy of Medicine in 2004.

  • Add a comment

  • Click here to Login/Register for free. You will be taken back to your selected item after Login/Registration.

Related content

Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »